Showing results (401-410 of 608) with videos related to

Sort By:
Pageof 61
Multiple Sclerosis Journal - Experimental, Translational and Clinical|May 5, 2021
Impact of natalizumab on quality of life in a real-world cohort of patients with multiple sclerosis: Results from MS PATHSCarrie M Hersh, Bernd Kieseier, Carl de Moor, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 25, 2022
Association between speech rate measures and cognitive function in people with relapsing and progressive multiple sclerosisClodagh O'Keeffe, Siew Mei Yap, Laura Davenport, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 27, 2023
Achieving no evidence of disease activity-3 in highly active multiple sclerosis patients treated with cladribine and monoclonal antibodiesRicardo Alonso, Magdalena Casas, Luciana Lazaro, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 11, 2021
Impact of the Swank and Wahls elimination dietary interventions on fatigue and quality of life in relapsing-remitting multiple sclerosis: The WAVES randomized parallel-arm clinical trialTerry L Wahls, Tyler J Titcomb, Babita Bisht, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|August 5, 2021
Preliminary testing of a patient decision aid for patients with relapsing-remitting multiple sclerosisNick Bansback, Judy A Chiu, Rebecca Metcalfe, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|February 23, 2023
New algorithmic approach for easier and faster extended disability status scale calculationAmr M Fouad, Maged Abdel Naseer, Marwa Farghaly, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|December 25, 2025
Multiple sclerosis relapse risk factors across treatment erasEvan Madill, Brian Healy, Mariann Polgar-Turcsanyi, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|November 3, 2025
The impact of early life stress on patient-reported outcomes in multiple sclerosisMyla Goldman, Shanshan Chen, Rylan Pearsall, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|October 13, 2025
Transition from anti-CD20 therapies to fumarates as a treatment strategy: A multicenter, retrospective observational experienceBrandi L Vollmer, Tammy Hoyt, Timothy W West, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 29, 2025
Validity and reliability of fatigue scale for motor and cognitive functions (FSMC) in an Iranian population of people with multiple sclerosisFarinaz Tabibian, Armin Adibi, Ali Motahharynia, et al.
Pageof 61